The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:


	Three Months Ended July 31,				Six Months Ended July 31,
	2026		2025		2026		2025
	(in thousands)
Cost of revenue	$	871	$	1,251	$	1,862	$	2,474
Research and development	5,027		9,174		10,460		17,788
Sales and marketing	1,770		2,876		3,652		5,955
General and administrative	3,297		4,915		5,587		9,862
Total stock-based compensation expense	$	10,965	$	18,216	$	21,561	$	36,079

As of July 31, 2026, the Company had unrecognized stock-based compensation expense related to RSUs and PRSUs (as defined below), and 2021 ESPP (as defined below) of $35.9 million, which is expected to be recognized over a weighted-average period of 2.0 years.

The 2021 Equity Incentive Plan (“2021 EIP”) allows the Company to grant stock options, stock appreciation rights, restricted stock units (“RSUs”), performance restricted stock units (“PRSUs”), and certain other awards. As of July 31, 2026, 1,131,989 shares of Common Stock were available under the 2021 EIP.

A summary of RSUs outstanding under the 2021 EIP as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	2,195,297	$	26.56
RSU granted	1,393,147	$	7.46
RSU vested	(845,171)	$	28.62
RSU forfeited	(284,253)	$	24.55
Outstanding as of July 31, 2026	2,459,020	$	15.26

Pursuant to the 2021 EIP, the Company has granted PRSUs to certain executive officers of the Company. Vesting of the PRSUs is dependent upon the satisfaction of both market- and service-based conditions occurring at the end of a four- or five- year period. The market-based condition is achieved if the closing price of the Company’s Common Stock is greater than or

equal to the applicable stock price appreciation target over a specified period at any time during the period beginning the date of the grant and ending on the expiration date.

Performance-based PRSUs are granted to certain employees, including executive officers, with vesting based on the achievement of specific financial goals, such as EBITDA. The grant date fair value of performance-based PRSUs is valued based on the Company’s stock price at the grant date. Stock-based compensation expense is recognized over the requisite service period based on the number of units expected to vest, which is reassessed during each reporting period based on the Company’s evaluation of the probability of achieving the applicable performance conditions.

A summary of PRSUs outstanding under the 2021 EIP as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	444,933	$	23.22
PRSUs granted	—	$	—

PRSU forfeited	—	$	—
Outstanding as of July 31, 2026	444,933	$	23.22

On January 15, 2026, ChargePoint's Board adopted the 2026 Inducement Plan to attract new employees by offering equity-based awards, without stockholder approval, under the NYSE inducement exemption. The plan authorizes up to 300,000 shares and is administered by the Compensation and Organizational Development Committee of the Board. During the three and six months ended July 31, 2026, 196,439 shares of Common Stock were issued under the Inducement Plan and 103,561 shares were reserved for future issuance.

The 2021 Employee Stock Purchase Plan (“2021 ESPP”) permits participants to purchase shares of the Company’s Common Stock at a discounted price through payroll deductions. As of July 31, 2026, 894,753 shares of Common Stock were available under the 2021 ESPP.

In fiscal year 2022, the Company terminated its 2017 Stock Option Plan (the “2017 Plan”) and 2007 Stock Option Plan (the “2007 Plan”).

A summary of stock options outstanding under the 2017 Plan and 2007 Plan as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Stock Option Awards	Weighted Average Exercise Price		Weighted Average Remaining Contractual term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2026	118,756	$	15.51	3.1	$	—

Options expired	(9,034)	$	14.31
Outstanding as of July 31, 2026	109,722	$	15.60	2.5	$	—
Options vested as of July 31, 2026	109,722	$	15.60	2.5	$	—
Exercisable as of July 31, 2026	109,722	$	15.60	2.5	$	—